APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

Saved in:
Bibliographic Details
Main Authors SULLIVAN GERARD M, SOUERS ANDREW J, WENDT MICHAEL D, DING HONG, PARK CHEOL-MIN, KUNZER AARON R, ELMORE STEVEN W, HEXAMER LAURA A
Format Patent
LanguageEnglish
Published 23.08.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Bibliography:Application Number: US201213458968